Regenerative Medicine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1066278
  • May 2021
  • Biotechnology
  • 121 Pages
The Regenerative Medicine Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Integra LifeSciences Corporation, Gilead Sciences, Novartis, Vericel Corporation, Wright Medical, MiMedx, Osiris Therapeutics, Stryker Corporation, Spark Therapeutics, Medtronic
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Regenerative Medicine market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Regenerative Medicine market is expected to attain Pre COVID-19 levels by mid-2022.

Regenerative Medicine Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Regenerative Medicine market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Regenerative Medicine Market Competitive and Premeditated Analysis
In the Regenerative Medicine report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Regenerative Medicine research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Regenerative Medicine Market:
The Regenerative Medicine market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Integra LifeSciences Corporation, Gilead Sciences, Novartis, Vericel Corporation, Wright Medical, MiMedx, Osiris Therapeutics, Stryker Corporation, Spark Therapeutics, Medtronic

The Regenerative Medicine market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Regenerative Medicine Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Regenerative Medicine market:
by Type
Cell-Based Immunotherapy and Cell Therapy Products
Tissue-Engineered Products
Gene Therapy Products
Application
Musculoskeletal Disorders
Wound Care
Oncology
Ocular Disorders
Diabetes

Regional Analysis of the Regenerative Medicine market:
The Regenerative Medicine market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Regenerative Medicine report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Regenerative Medicine market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Regenerative Medicine market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Regenerative Medicine market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Regenerative Medicine market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Regenerative Medicine market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Regenerative Medicine market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Regenerative Medicine market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Regenerative Medicine market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Integra LifeSciences Corporation
  • Gilead Sciences
  • Novartis
  • Vericel Corporation
  • Wright Medical
  • MiMedx
  • Osiris Therapeutics
  • Stryker Corporation
  • Spark Therapeutics
  • Medtronic
  • Cell-Based Immunotherapy and Cell Therapy Products
  • Tissue-Engineered Products
  • Gene Therapy Products
  • Musculoskeletal Disorders
  • Wound Care
  • Oncology
  • Ocular Disorders
  • Diabetes

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Regenerative Medicine Market Snapshot
          2.1.1. Global Regenerative Medicine Market By Type,2019
               2.1.1.1.Cell-Based Immunotherapy and Cell Therapy Products
               2.1.1.2.Tissue-Engineered Products
               2.1.1.3.Gene Therapy Products
          2.1.2. Global Regenerative Medicine Market By Application,2019
               2.1.2.1.Musculoskeletal Disorders
               2.1.2.2.Wound Care
               2.1.2.3.Oncology
               2.1.2.4.Ocular Disorders
               2.1.2.5.Diabetes
          2.1.3. Global Regenerative Medicine Market By End-use,2019
          2.1.4. Global Regenerative Medicine Market By Geography,2019

3. Global Regenerative Medicine Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Regenerative Medicine Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Regenerative Medicine Market Size (US$), By Type, 2018 – 2028

5. Global Regenerative Medicine Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Regenerative Medicine Market Size (US$), By Application, 2018 – 2028

6. Global Regenerative Medicine Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Regenerative Medicine Market Size (US$), By End-use, 2018 – 2028

7. Global Regenerative Medicine Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Regenerative Medicine Market Analysis, 2018 – 2028 
          7.2.1. North America Regenerative Medicine Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Regenerative Medicine Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Regenerative Medicine Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Regenerative Medicine Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Regenerative Medicine Market Analysis, 2018 – 2028 
          7.3.1.  Europe Regenerative Medicine Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Regenerative Medicine Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Regenerative Medicine Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Regenerative Medicine Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Regenerative Medicine Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Regenerative Medicine Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Regenerative Medicine Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Regenerative Medicine Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Regenerative Medicine Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Regenerative Medicine Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Regenerative Medicine Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Regenerative Medicine Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Regenerative Medicine Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Regenerative Medicine Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Regenerative Medicine Market Analysis, 2018 – 2028 
          7.6.1.  MEA Regenerative Medicine Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Regenerative Medicine Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Regenerative Medicine Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Regenerative Medicine Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Regenerative Medicine Providers
        8.4.1 Integra LifeSciences Corporation
                8.4.1.1 Business Description
                8.4.1.2 Integra LifeSciences Corporation Geographic Operations
                8.4.1.3 Integra LifeSciences Corporation Financial Information
                8.4.1.4 Integra LifeSciences Corporation Product Positions/Portfolio
                8.4.1.5 Integra LifeSciences Corporation Key Developments
        8.4.2 Gilead Sciences
                8.4.2.1 Business Description
                8.4.2.2 Gilead Sciences Geographic Operations
                8.4.2.3 Gilead Sciences Financial Information
                8.4.2.4 Gilead Sciences Product Positions/Portfolio
                8.4.2.5 Gilead Sciences Key Developments
        8.4.3 Novartis
                8.4.3.1 Business Description
                8.4.3.2 Novartis Geographic Operations
                8.4.3.3 Novartis Financial Information
                8.4.3.4 Novartis Product Positions/Portfolio
                8.4.3.5 Novartis Key Developments
        8.4.4 Vericel Corporation
                8.4.4.1 Business Description
                8.4.4.2 Vericel Corporation Geographic Operations
                8.4.4.3 Vericel Corporation Financial Information
                8.4.4.4 Vericel Corporation Product Positions/Portfolio
                8.4.4.5 Vericel Corporation Key Developments
        8.4.5 Wright Medical
                8.4.5.1 Business Description
                8.4.5.2 Wright Medical Geographic Operations
                8.4.5.3 Wright Medical Financial Information
                8.4.5.4 Wright Medical Product Positions/Portfolio
                8.4.5.5 Wright Medical Key Developments
        8.4.6 MiMedx
                8.4.6.1 Business Description
                8.4.6.2 MiMedx Geographic Operations
                8.4.6.3 MiMedx Financial Information
                8.4.6.4 MiMedx Product Positions/Portfolio
                8.4.6.5 MiMedx Key Developments
        8.4.7 Osiris Therapeutics
                8.4.7.1 Business Description
                8.4.7.2 Osiris Therapeutics Geographic Operations
                8.4.7.3 Osiris Therapeutics Financial Information
                8.4.7.4 Osiris Therapeutics Product Positions/Portfolio
                8.4.7.5 Osiris Therapeutics Key Developments
        8.4.8 Stryker Corporation
                8.4.8.1 Business Description
                8.4.8.2 Stryker Corporation Geographic Operations
                8.4.8.3 Stryker Corporation Financial Information
                8.4.8.4 Stryker Corporation Product Positions/Portfolio
                8.4.8.5 Stryker Corporation Key Developments
        8.4.9 Spark Therapeutics
                8.4.9.1 Business Description
                8.4.9.2 Spark Therapeutics Geographic Operations
                8.4.9.3 Spark Therapeutics Financial Information
                8.4.9.4 Spark Therapeutics Product Positions/Portfolio
                8.4.9.5 Spark Therapeutics Key Developments
        8.4.10 Medtronic
                8.4.10.1 Business Description
                8.4.10.2 Medtronic Geographic Operations
                8.4.10.3 Medtronic Financial Information
                8.4.10.4 Medtronic Product Positions/Portfolio
                8.4.10.5 Medtronic Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Regenerative Medicine Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Regenerative Medicine Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Regenerative Medicine Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Regenerative Medicine Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Regenerative Medicine Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Regenerative Medicine Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Regenerative Medicine Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Regenerative Medicine Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Regenerative Medicine Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Regenerative Medicine Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Regenerative Medicine Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Regenerative Medicine Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Regenerative Medicine Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Regenerative Medicine Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Regenerative Medicine Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Regenerative Medicine Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Regenerative Medicine: Market Segmentation 
FIG. 2 Global Regenerative Medicine Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Regenerative Medicine Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Regenerative Medicine Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Regenerative Medicine Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Regenerative Medicine Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Regenerative Medicine Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Regenerative Medicine Providers, 2019
FIG. 11 Global Regenerative Medicine Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Regenerative Medicine Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Regenerative Medicine Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Regenerative Medicine Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Regenerative Medicine Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Regenerative Medicine Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Regenerative Medicine Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Regenerative Medicine Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Regenerative Medicine market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Regenerative Medicine Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Regenerative Medicine Market Value, By Segment1, 2018 – 2028
TABLE  North America Regenerative Medicine Market Value, By Segment2, 2018 – 2028
TABLE  North America Regenerative Medicine Market Value, By Country, 2018 – 2028
TABLE  Europe Regenerative Medicine Market Value, By Segment1, 2018 – 2028
TABLE  Europe Regenerative Medicine Market Value, By Segment2, 2018 – 2028
TABLE  Europe Regenerative Medicine Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Regenerative Medicine Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Regenerative Medicine Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Regenerative Medicine Market Value, By Country, 2018 – 2028
TABLE  Latin America Regenerative Medicine Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Regenerative Medicine Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Regenerative Medicine Market Value, By Country, 2018 – 2028
TABLE  MEA Regenerative Medicine Market Value, By Segment1, 2018 – 2028
TABLE  MEA Regenerative Medicine Market Value, By Segment2, 2018 – 2028
TABLE  MEA Regenerative Medicine Market Value, By Country, 2018 – 2028
TABLE  Integra LifeSciences Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Gilead Sciences: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novartis: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Vericel Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Wright Medical: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  MiMedx: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Osiris Therapeutics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Stryker Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Spark Therapeutics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Medtronic: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Regenerative Medicine Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Regenerative Medicine Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Regenerative Medicine Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Regenerative Medicine Market, By Geography, 2019 (US$ Mn)
FIG.  Global Regenerative Medicine Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Regenerative Medicine Providers, 2016
FIG.  Global Regenerative Medicine Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Tissue-Engineered Products Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Gene Therapy Products Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Regenerative Medicine Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Wound Care Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Oncology Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Ocular Disorders Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Diabetes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Regenerative Medicine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Regenerative Medicine Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Regenerative Medicine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Regenerative Medicine Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Regenerative Medicine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Regenerative Medicine Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Regenerative Medicine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Regenerative Medicine Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Regenerative Medicine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Regenerative Medicine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Regenerative Medicine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Regenerative Medicine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Regenerative Medicine Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Regenerative Medicine Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Regenerative Medicine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Regenerative Medicine Market Value, 2018 – 2028, (US$ Mn)